What is the primary treatment for asthma?

The primary treatment for asthma focuses on the use of short-acting bronchodilators, commonly referred to as short-acting beta-agonists (SABAs). These medications, such as albuterol, work by relaxing the bronchial smooth muscle, leading to rapid relief of asthma symptoms such as wheezing, shortness of breath, and chest tightness. SABAs are especially effective for acute asthma exacerbations and can provide immediate relief when symptoms arise.

While long-acting medications, inhaled corticosteroids, and other treatments play important roles in the long-term management of asthma, short-acting bronchodilators are typically utilized for quick relief during an asthma attack. Their rapid onset of action makes them a cornerstone in the acute management of asthma symptoms.

In contrast, long-acting oral steroids, inhaled antihistamines, and intravenous immunoglobulin have different indications and are not considered primary treatments for acute asthma management. Long-acting oral steroids are generally used for chronic control in more severe cases, while antihistamines are more relevant in managing allergic symptoms rather than bronchospasm. Intravenous immunoglobulin is used for specific immunological conditions, not for asthma management.